If one were smart you would think stroke hospitals would use this post tPA to immediately identify those cases of brain bleeds and work to stop them. IF YOU WERE SMART!
Zynex Obtains European Patent for Blood Volume Monitor
ENGLEWOOD, Colo., Feb. 3, 2020 /PRNewswire/
-- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company
specializing in the manufacture and sale of non-invasive medical devices
for pain management, stroke rehabilitation, cardiac monitoring and
neurological diagnostics, announced today that it has obtained a
European patent for its Blood Volume Monitor Device. Thomas Sandgaard, the inventor, has assigned the patent to Zynex's subsidiary, Zynex Monitoring Solutions.
Zynex
Thomas Sandgaard,
CEO said: "I am excited to have obtained European patent protection for
the core principles of how we detect fluid imbalances such as excessive
blood loss during surgery or internal bleeding in recovery. We received
a U.S. Utility Patent protection on the device about a year ago and
believe this will strengthen our competitive position in the market for
better fluid management in hospitals and surgical centers. This
breakthrough technology is unique as there are no other non-invasive
devices available that can detect blood loss or internal bleeding.
We
believe our non-invasive, easy-to-operate technology will serve an
unmet need to manage blood volume in hospital and surgical settings,
whether it is fluid loss, fluid overload or internal bleeding which is
rarely detected until it becomes critical or fatal. It should be noted,
we are still awaiting FDA clearance and European CE marking to fully
launch the product into the market.
We
believe lives can be saved with this technology as significant
complications are avoided during surgery. Fluid management issues can
cause organs to malfunction and make recovery more difficult.
No comments:
Post a Comment